Tollefsen D M
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
Ann N Y Acad Sci. 1994 Apr 18;714:21-31. doi: 10.1111/j.1749-6632.1994.tb12027.x.
The binding sites for dermatan sulfate and heparin in HCII overlap but are not identical. This may explain the observation that HCII binds nonspecifically to heparin oligosaccharides, but preferentially binds to a minor hexasaccharide isolated from dermatan sulfate. The tissue distribution of dermatan sulfate molecules containing the high-affinity HCII binding site may regulate HCII activity in vivo. Finally, in the presence of dermatan sulfate or heparin, the N-terminal acidic region of HCII may interact with the hirudin-binding site of thrombin to produce maximal stimulation of the thrombin-HCII reaction.
硫酸皮肤素和肝素在人凝血酶抑制因子(HCII)中的结合位点相互重叠但并不完全相同。这或许可以解释为何HCII能非特异性地结合肝素寡糖,但却更倾向于结合从硫酸皮肤素中分离出的一种次要的六糖。含有高亲和力HCII结合位点的硫酸皮肤素分子的组织分布可能在体内调节HCII的活性。最后,在存在硫酸皮肤素或肝素的情况下,HCII的N端酸性区域可能与凝血酶的水蛭素结合位点相互作用,从而对凝血酶 - HCII反应产生最大程度的刺激。